Let's focus on what we can do!

Facebook Twitter Instagram Linkedin
What are you looking for?

By Disabled People for Disabled People

  • Home
  • >
  • Latest Headlines
  • >
  • Target Enrollment in Child Spinal Muscular Atrophy Study Earns Ionis $2M Payment From Biogen – SMA News Today

Target Enrollment in Child Spinal Muscular Atrophy Study Earns Ionis $2M Payment From Biogen – SMA News Today

Sunday, 31 January, 2016

Categories

Target Enrollment in Child Spinal Muscular Atrophy Study Earns Ionis $2M Payment From Biogen – SMA News Today

Ionis Pharmaceuticals announced it has completed its target enrollment of the Phase 3 CHERISH study, a trial designed to support marketing approval of the drug candidate nusinersen in children with spinal muscular atrophy (SMA). The achievement earned ...

Read More

Source:Target Enrollment in Child Spinal Muscular Atrophy Study Earns Ionis $2M Payment From Biogen - SMA News Today

Categories :
  • Latest Headlines , 
  • Spinal muscular atrophy , 
  • Uncategorized
Socials :

Recent posts

@abilitytoday
Let's share our
memories
@abilitytodayuk
Let's be
friends
@abilitytoday
Let's chat and hear
your voice
@ability-today
Let's get down to
Business
Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Our Awards and Partners

Disability confident Logo
Donate to Ability Today CIC
(A Social Enterprise)

Copyright © 2023 All rights reserved

Facebook Twitter Instagram Linkedin